These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15111929

  • 1. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
    Streeter PR, Zhang X, Tittle TV, Schön CN, Weinberg AD, Maziarz RT.
    Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
    [Abstract] [Full Text] [Related]

  • 2. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J, Casaño J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, Serrano J, Herrera C, Torres A.
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M, Briones J, Canto E, Sabzevari H, Martino R, Sierra J, Rodriguez-Sanchez JL, Vidal S.
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
    Wilde B, Dolff S, Cai X, Specker C, Becker J, Tötsch M, Costabel U, Dürig J, Kribben A, Tervaert JW, Schmid KW, Witzke O.
    Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
    [Abstract] [Full Text] [Related]

  • 8. Thiol levels in CD134-defined subsets of rat T lymphocytes: possible implications for HgCl2-induced immune dysregulation.
    Roos A, Claessen N, Schilder-Tol EJ, Chand MA, Weening JJ, Aten J.
    Biochem Biophys Res Commun; 1997 Nov 17; 240(2):452-7. PubMed ID: 9388500
    [Abstract] [Full Text] [Related]

  • 9. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
    Mutis T, Aarts-Riemens T, Verdonck LF.
    Haematologica; 2005 Oct 17; 90(10):1389-95. PubMed ID: 16219576
    [Abstract] [Full Text] [Related]

  • 10. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T, Ishikawa T, Fukunaga A, Hori T, Uchiyama T.
    Biol Blood Marrow Transplant; 2008 Mar 17; 14(3):268-81. PubMed ID: 18275893
    [Abstract] [Full Text] [Related]

  • 11. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS.
    Nat Med; 2003 Sep 17; 9(9):1144-50. PubMed ID: 12925844
    [Abstract] [Full Text] [Related]

  • 12. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M, do Carmo Leite-de-MoraesM, Pontoux C, Joret AM, Rocha B, Penit C, Dy M.
    J Immunol; 1997 May 15; 158(10):4642-53. PubMed ID: 9144476
    [Abstract] [Full Text] [Related]

  • 13. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
    Huddleston CA, Weinberg AD, Parker DC.
    Eur J Immunol; 2006 May 15; 36(5):1093-103. PubMed ID: 16541471
    [Abstract] [Full Text] [Related]

  • 14. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC, Friedman TM, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2004 Feb 15; 10(2):91-105. PubMed ID: 14750075
    [Abstract] [Full Text] [Related]

  • 15. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.
    Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL.
    J Clin Invest; 2003 Dec 15; 112(11):1688-96. PubMed ID: 14660744
    [Abstract] [Full Text] [Related]

  • 16. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A.
    Transplantation; 2007 Jul 15; 84(1):31-9. PubMed ID: 17627234
    [Abstract] [Full Text] [Related]

  • 17. Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.
    Xia G, Kovochich M, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2004 Nov 15; 10(11):748-60. PubMed ID: 15505606
    [Abstract] [Full Text] [Related]

  • 18. CD4+CD25+ regulatory T cells and graft-versus-host disease.
    Hoffmann P, Edinger M.
    Semin Hematol; 2006 Jan 15; 43(1):62-9. PubMed ID: 16412790
    [Abstract] [Full Text] [Related]

  • 19. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.
    Hall BM, Robinson CM, Plain KM, Verma ND, Carter N, Boyd RA, Tran GT, Hodgkinson SJ.
    Transpl Immunol; 2008 Feb 15; 18(4):291-301. PubMed ID: 18158114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.